Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...

Evotec's other major shareholders are Novo Nordisk (NOVOb.CO ... ago Healthcare & Pharmaceuticalscategory Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says 8:27 AM ...

The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...

Novo Nordisk, Perfood, PharmaSens, Roche, Sinocare, Terumo, and Ypsomed. Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape ...

Major players in the U.S., such as AstraZeneca, Merck, Sanofi, Novo Nordisk, Eli Lilly, Ypsomed AG, Consort Medical Plc, BD, Amgen, Enable Injections, Insulet Corporation, and others are significantly ...

Over the last couple of years, Danish company Novo Nordisk (NYSE: NVO) has evolved from a relatively obscure pharmaceutical business to perhaps the biggest rising star in healthcare. The company's ...